Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John Hagaman
Anatomical Differences and Atherosclerosis in Apolipoprotein E-Deficient Mice With 129/SvEv and C57bl/6 Genetic Backgrounds
Atherosclerosis
Cardiovascular Medicine
Cardiology
Related publications
597. Therapy of Atherosclerosis in Apolipoprotein E-Deficient Mice
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice
Mediators of Inflammation
Immunology
Cell Biology
Acyl-CoA:Cholesterol Acyltransferase Inhibition Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E-Deficient Mice
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Apolipoprotein E Regulates Dietary Cholesterol Absorption and Biliary Cholesterol Excretion: Studies in C57bl/6 Apolipoprotein E Knockout Mice
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Paradoxical Enhancement of Atherosclerosis by Probucol Treatment in Apolipoprotein E-Deficient Mice.
Journal of Clinical Investigation
Medicine
Inhibition of Endoplasmic Reticulum Stress and Atherosclerosis by 2-Aminopurine in Apolipoprotein E-Deficient Mice
ISRN Pharmacology
Association of Multiple Cellular Stress Pathways With Accelerated Atherosclerosis in Hyperhomocysteinemic Apolipoprotein E-Deficient Mice
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Deficiency of Acyl CoA:cholesterol Acyltransferase 2 Prevents Atherosclerosis in Apolipoprotein E-Deficient Mice
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary